Inventiva (IVA) Non Operating Interest Expenses (2020 - 2021)
Inventiva's (IVA) quarterly Non Operating Interest Expenses came in at -$30155.9 in Q1 2021, down 2631.66% year-on-year from $1191.1 in Q1 2020, and down 2631.66% quarter-over-quarter from -$1103.9 in Q1 2020.
Inventiva (IVA) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends
Inventiva's Non Operating Interest Expenses history runs 2 years deep, the most recent figure standing at -$30155.9 for Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -220,921.81 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -30,155.90 |
| Mar 31, 2020 | -1,103.94 |